Chemical Compound
4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]-benzenesulfonamide; 4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzenesulfonamide; 4-[5-(3-Fluoro-4-methoxyphenyl)-3-(difluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; Deracoxib; Deram; Deramaxx; SC 046; SC 46; SC 59046
CAS Registry Number
169590-41-4
Primary record
4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]-benzenesulfonamide; 4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzenesulfonamide; 4-[5-(3-Fluoro-4-methoxyphenyl)-3-(difluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; Deracoxib; Deram; Deramaxx; SC 046; SC 46; SC 59046
- 库存
- 9,959 克
- 纯度
- 99.4 %
- CAS
- 169590-41-4
化合物标识与属性
- CAS
- 169590-41-4
- PubChem CID
- 3058754
- SMILES
- COC1=C(C=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)F)F
- Canonical SMILES
- COc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1F
名称与同义词
- Deracoxib
- Deramaxx
- 169590-41-4
- Deram
- deracoxibum
- Doxidyl
- Rederox
- Coxiba
- OstiMax
- OstiMax Chewable
- Deracoxib-d4
- Deracoxib [USAN]
- Deracoxib Chewable
- DOXIDYL Chewable
- Deracoxib (USAN)
- C17H14F3N3O3S
- VX29JB5XWV
- Deracoxib [USAN:INN]
- SC 46
- UNII-VX29JB5XWV
- DERACOXIB [INN]
- RefChem:54945
- DERACOXIB [MI]
- Deramaxx Chewable Tablets
- Spectrum2_000521
- Spectrum3_001677
- Spectrum4_001227
- Spectrum5_001644
- 4-(3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)benzenesulfonamide
- Deracoxib Chewable Tablets
- DTXSID4045975
- MFCD09837763
- SC 046
- SC-59046
- CHEMBL28636
- AC1MHW65
- DERACOXIB [WHO-DD]
- SC 59046
- SCHEMBL24645
- BSPBio_003493
- DTXCID2025975
- KBioGR_001694
- CHEBI:73032
- NSC-758935
- SPBio_000501
- DERACOXIB [GREEN BOOK]
- WAZQAZKAZLXFMK-UHFFFAOYSA-N
- orb1310568
- SCHEMBL29593653
- ERK5-3P07
- KBio3_002713
- EX-A887
- SC-046
- GLXC-06319
- HMS2093M12
- HMS3886O18
- Pharmakon1600-01505222
- SC-46
- ZINC607803
- AMY31402
- BCP04295
- KS-00000G0A
- UWC78024
- Tox21_111503
- BDBM50057583
- CCG-39562
- MSK4067-100M
- NCGC00095312-01
- NSC758935
- s5711
- AKOS016009604
- Tox21_111503_1
- ACN-029036
- BCP9000598
- CID3058754
- CS-2107
- CS-W-00227
- DB11395
- FD21070
- NSC 758935
- C17-H14-F3-N3-O3-S
- NCGC00095312-02
- NCGC00095312-04
- 1-Propanol, 2,2-dimethyl-, 1-benzoate
- 4CA-0448
- AC-33031
- AJ-23690
- AK-60962
- AS-19558
- HY-17509
- SY102730
- BCP0726000080
- Deracoxib Solution in Methanol, 100ug/mL
- SBI-0206729.P001
- AB0035926
- DB-348585
- 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzenesulfonamide
- B1091
- CAS-169590-41-4
- FT-0665858
- NS00040614
- ST24042879
- Y0377
- J2.162.792E
- D03689
- AB01563051_01
- A852660
- SR-05000001985
- Q5261287
- SR-05000001985-1
- 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)pyrazol-1-yl]benzenesulfonamide
- BRD-K68558722-001-02-4
- BRD-K68558722-001-04-0
- 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide
- 4-[5-(3-Fluoro-4-methoxyphenyl)-3-(difluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
- Benzenesulfonamide, 4-(3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)-
- Benzenesulfonamide, 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]-
- 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxy-phenyl)pyrazol-1-yl]benzenesulfonamide
- 4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazole-1-yl]benzenesulfonamide
- 4-[3-Difluoromethyl-5-(3-fluoro-4-methoxy-phenyl)-pyrazol-1-yl]-benzenesulfonamide
- 1794780-24-7
- 4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]-benzenesulfonamide; 4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzenesulfonamide; 4-[5-(3-Fluoro-4-methoxyphenyl)-3-(difluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; Deracoxib; Deram; Deramaxx; SC 046; SC 46; SC 59046
- 807-307-6